Keith Kellerman is an experienced professional in the biopharmaceutical sector, currently serving as Director of MSAT in Manufacturing Technical Services at Vertex Pharmaceuticals since July 2023. Prior to this role, Kellerman was Director of CMC Technical Operations at Pfizer and Global Blood Therapeutics, where responsibilities included overseeing external operations for multiple CDMOs and CROs, as well as managing CMC strategies for late-stage biotherapeutics. With a long tenure at Lonza, Kellerman progressed from Purification Development Scientist to MSAT Lead and Asset Business Partner, significantly expanding the MSAT organization and managing complex facility projects. Educational qualifications include a BS in Biology and Chemistry from Plymouth State University and graduate coursework in Bioprocess Engineering from the University of Massachusetts Lowell.
This person is not in any teams
This person is not in any offices